BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25185018)

  • 1. Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.
    Kim HJ; Park M; Park HC; Jeong JC; Kim DK; Joo KW; Hwang YH; Yang J; Ahn C; Oh KH
    Perit Dial Int; 2016; 36(1):26-32. PubMed ID: 25185018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum fibroblast growth factor 23 concentration and the risk of mortality in patients undergoing peritoneal dialysis.
    Zhong Z; Feng S; Fu D; Li B; Li Z; Mao H
    Perit Dial Int; 2024 May; 44(3):194-202. PubMed ID: 38449341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Taniguchi M; Yoshida H; Tokumoto M; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal aortic calcification score as a predictor of clinical outcome in peritoneal dialysis patients: a prospective cohort study.
    Ma D; Yan H; Yang X; Yu Z; Ni Z; Fang W
    BMC Nephrol; 2020 Apr; 21(1):151. PubMed ID: 32349690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
    Nishizawa Y; Hosoda Y; Horimoto A; Omae K; Ito K; Higuchi C; Sakura H; Nitta K; Ogawa T
    Heart Vessels; 2021 Mar; 36(3):414-423. PubMed ID: 33000285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in echocardiographic parameters according to the rate of residual renal function decline in incident peritoneal dialysis patients.
    Koo HM; Doh FM; Kim CH; Lee MJ; Kim EJ; Han JH; Han JS; Ryu DR; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
    Medicine (Baltimore); 2015 Feb; 94(7):e427. PubMed ID: 25700308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
    Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
    Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of arterial stiffness on adverse cardiovascular outcomes and mortality in peritoneal dialysis patients.
    Sipahioglu MH; Kucuk H; Unal A; Kaya MG; Oguz F; Tokgoz B; Oymak O; Utas C
    Perit Dial Int; 2012; 32(1):73-80. PubMed ID: 21454392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients.
    Sugimoto H; Ogawa T; Iwabuchi Y; Otsuka K; Nitta K
    Int Urol Nephrol; 2014 Jan; 46(1):99-106. PubMed ID: 23355029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.
    Jovanovich A; You Z; Isakova T; Nowak K; Cheung A; Wolf M; Chonchol M; Kendrick J
    Am J Nephrol; 2019; 49(4):263-270. PubMed ID: 30820005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.
    Paul S; Wong M; Akhabue E; Mehta RC; Kramer H; Isakova T; Carnethon MR; Wolf M; Gutiérrez OM
    J Am Heart Assoc; 2021 Aug; 10(16):e020196. PubMed ID: 34387090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alkaline phosphatase levels correlate with long-term mortality solely in peritoneal dialysis patients with residual renal function.
    Zhan X; Yang Y; Chen Y; Wei X; Xiao J; Zhang L; Yan C; Qiu P; Liu S; Hu Q; Chen Q; Wang Y
    Ren Fail; 2019 Nov; 41(1):718-725. PubMed ID: 31409217
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients.
    Dong J; Li YJ; Yang ZK; Xu R
    Perit Dial Int; 2014; 34(7):706-13. PubMed ID: 24584618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
    Moe SM; Chertow GM; Parfrey PS; Kubo Y; Block GA; Correa-Rotter R; Drüeke TB; Herzog CA; London GM; Mahaffey KW; Wheeler DC; Stolina M; Dehmel B; Goodman WG; Floege J;
    Circulation; 2015 Jul; 132(1):27-39. PubMed ID: 26059012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
    Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
    JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of decline of residual renal function in new peritoneal dialysis patients.
    Johnson DW; Mudge DW; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Hollett P
    Perit Dial Int; 2003; 23(3):276-83. PubMed ID: 12938830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoprotein(a) and risk of mortality in patients on peritoneal dialysis.
    Zhong Z; Peng F; Shi D; Peng Y; Li B; Xiao M; Feng S; Mao H; Huang F; Yang X; Li J; Li Z
    J Clin Lipidol; 2020; 14(2):252-259. PubMed ID: 32081604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dialysis is a reasonable option in patients with cardiovascular disease
.
    Querido S; Quadros Branco P; Silva Sousa H; Adragão T; Araújo Gonçalves P; Gaspar MA; Diogo Barata J
    Clin Nephrol; 2017 Mar; 87 (2017)(3):111-116. PubMed ID: 28128728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.